Heart rate elevation does not predict how bad you feel

Boris published a 2020 paper in Pediatric Cardiology examining the relationship between orthostatic heart rate elevation and reported symptom burden in a pediatric population with chronic orthostatic intolerance. The finding was direct and consequential: the magnitude of the orthostatic heart rate increase — the primary metric used to diagnose POTS, the number that clinicians watch during tilt, the threshold that determines whether a patient gets a diagnosis — showed no statistically significant association with how symptomatic the patients reported feeling. A large heart rate rise did not predict more disabling symptoms. A smaller rise did not predict less disabling symptoms. The number on the monitor was not telling the story that everyone assumed it was telling.

What Heart Rate Is Actually Measuring in Orthostatic Intolerance

To understand why heart rate elevation fails as a severity marker, it helps to understand what the heart rate elevation is actually doing. Tachycardia in orthostatic intolerance is not the problem. It is the autonomic system's attempt to solve a problem. When a person stands, venous blood pools in the legs and abdomen. Venous return to the heart decreases. Cardiac output falls. The autonomic system detects this and responds by accelerating the heart rate to increase stroke frequency and partially compensate for the reduced stroke volume. The goal is to maintain cardiac output — and specifically to maintain cerebral blood flow — despite the postural hemodynamic challenge.

In this framing, the tachycardia is compensatory. It is the body doing what it can to keep the brain perfused. The degree of tachycardia reflects the magnitude of the compensatory effort, not the magnitude of the underlying failure. And the success of that compensation — whether cerebral blood flow is actually maintained despite the effort — depends on factors that the heart rate number does not capture: blood volume, vascular tone, cerebrovascular autoregulation, CO₂ levels, and the efficiency of venous return mechanisms.

Two patients can produce a 40 bpm orthostatic heart rate rise from entirely different physiological starting points, with entirely different downstream effects on cerebral perfusion, and experience entirely different symptom burdens. The heart rate tells you how hard the system is working. It does not tell you whether the work is succeeding.

Why a Larger Heart Rate Rise Can Indicate Better, Not Worse, Compensation

The counterintuitive implication of the compensatory framing is that, in some circumstances, a larger orthostatic tachycardia may actually reflect a more capable compensatory response rather than a more severe underlying problem. A patient whose autonomic system generates a robust 50 bpm rise in response to standing may be maintaining cerebral perfusion more effectively than a patient whose dysregulated system produces only a 30 bpm rise but whose cerebrovascular regulation is also impaired.

This is speculative at the level of the individual patient — the relationship between heart rate compensation and actual cerebral perfusion is complex and involves multiple interacting variables. But it is consistent with the Boris finding that the number itself does not predict symptoms, and it is consistent with the broader literature showing that cerebral blood flow can be impaired despite apparently adequate cardiovascular compensation.

The point is not that a higher heart rate rise is better. The point is that the heart rate rise, considered in isolation, is not a reliable index of how much the brain is actually receiving. The symptom — fatigue, brain fog, cognitive slowing, visual changes, nausea — is generated by inadequate cerebral perfusion. The heart rate rise is one component of the system trying to prevent that inadequate perfusion. The two are related but not equivalent, and treating them as equivalent is the error this paper quantifies.

The Clinical Problem of Using Tachycardia as a Severity Proxy

In clinical practice, the orthostatic heart rate increase plays two roles that the Boris data suggest it cannot reliably perform simultaneously. The first role is diagnostic: meeting the 30 bpm threshold (or 40 bpm in adolescents) establishes the POTS diagnosis. For this role, the heart rate criterion is appropriate — it is a defined, measurable threshold that separates POTS from normal orthostatic physiology.

The second role is the problematic one: using the same number as an informal severity gauge, treatment outcome measure, or eligibility criterion for accommodations and functional limitations. When a clinician says "your heart rate only went up 32 beats, that's barely above threshold, so you don't have severe POTS," they are using the diagnostic metric as a severity metric. The Boris data show these are not the same thing.

Similarly, when a patient's orthostatic tachycardia is reduced by a beta blocker and the clinician interprets the lower number as evidence of improvement — without measuring symptoms, functional capacity, or what the patient is actually experiencing — the treatment response is being assessed by the compensatory metric rather than by the outcome the treatment was intended to produce. A patient whose heart rate is now 28 bpm over baseline instead of 40 bpm over baseline, and who feels worse, is not better. The number improved. The problem did not.

What Should Be Measured Instead

The Boris paper does not specify a replacement metric, but the mechanistic logic of the finding points toward the same conclusion that other lines of research in this registry have reached: the relevant outcome measure is what is happening to cerebral blood flow, not what is happening to heart rate.

Transcranial Doppler measurement of cerebral blood flow velocity during orthostatic challenge provides a direct index of what the brain is actually receiving during the postural stress. Blood volume measurement quantifies one of the primary inputs to the compensatory system. CO₂ monitoring captures the hyperventilation-mediated vasoconstriction pathway that operates independently of the heart rate compensation. Symptom burden questionnaires, validated for orthostatic intolerance, measure the functional output that all of these physiological processes ultimately determine.

None of these measurements are routinely performed in the standard tilt table evaluation that most POTS patients receive. The standard evaluation measures heart rate and blood pressure, establishes the diagnostic threshold, and stops. The Boris finding establishes that stopping there leaves the clinician without information about severity, without a useful outcome measure for treatment, and without any way to explain why patients with apparently similar tilt table profiles can have dramatically different functional capacities.

The Implication for Patients Told Their POTS Is Mild

If you have been told that your POTS is mild because your heart rate elevation was only slightly above the diagnostic threshold, or because your number improved on medication even though your symptoms did not, or because your tilt table numbers do not match the severity of your disability — the Boris paper is your reference point. It establishes, in a peer-reviewed population study, that the size of the orthostatic heart rate rise does not predict symptom burden. A small rise does not mean mild illness.

The corollary is equally important for patients on beta blockers or ivabradine who have had their heart rate numbers normalized but who continue to experience disabling symptoms. The normalization of the tachycardia is not the same as the normalization of the underlying hemodynamics that the tachycardia was compensating for. If the venous pooling, the reduced blood volume, the impaired cerebrovascular autoregulation, or the CO₂ dysregulation that produced the original tachycardic compensation are still present, removing the compensation without addressing its drivers leaves the patient with the underlying problem and less of the body's attempt to manage it.

What you now know is that the metric used to diagnose POTS is not the metric that reflects how sick you are. The heart rate is the system straining to compensate. The symptom is what happens when the compensation is insufficient. Those are two different measurements of two different things, and confusing them has been producing inadequate clinical assessments for as long as heart rate has been the primary number anyone bothers to look at.